RxFul pricing for clinics

What does RxFul pricing mean for a clinic P&L?

On a clinic P&L, RxFul adds a fixed monthly SaaS line — from $0 on the GLP-only tier through $1,997/mo on Gold — plus variable fulfillment and compounded medication cost that RxFul does not publish. Bronze at $997/mo is the entry point for the full formulary including peptides and hormones. Until you confirm per-vial drug and fulfillment rates at onboarding, you are modeling gross margin on GLP-1 and hormone programs with a known platform cost but an unknown COGS line.

This page looks at RxFul pricing through the clinic owner's P&L lens — what you can plan from published tiers, what you must confirm, and how visible per-vial cost changes margin math.

Compare Fizy Health vs RxFul

Proudly Partnered With

How RxFul pricing shows up on a clinic P&L

Cash-pay clinics book compounded medications as cost of goods sold. RxFul splits that COGS story into two lines you model differently. The platform line is published: $0, $997, $1,497, or $1,997 per month depending on tier. The drug and fulfillment line is not published — it arrives through onboarding, often with volume-based fulfillment pricing on Silver and Gold. A clinic running semaglutide at volume might budget $997/mo for Bronze and still not know per-vial COGS until after portal setup, which makes patient program pricing harder to lock before launch.

What a clinic owner can plan from published tiers

You can budget the platform row today. A GLP-only telehealth brand testing demand might start on Rx-GLP at $0/mo and accept catalog limits. A med spa adding peptides and TRT needs Bronze at minimum — that is $11,964 per year in fixed SaaS before a single vial ships. Silver and Gold add fulfillment volume economics, marketing tooling, and API access; model whether those features justify the incremental monthly fee against your order count.

What you cannot plan from rxful.com alone is per-vial compounded cost and per-order fulfillment. Ask for written rates on your top five SKUs at your expected monthly volume, including cold-chain surcharges if you ship GLP-1s nationally. Build margin on the all-in landed cost per patient line, not the SaaS tier headline alone.

Why visible per-vial cost simplifies the margin model

Fizy Health inverts the planning problem for prescriber-side ordering. Resolved per-vial 503A cost appears on each catalog and cart line before checkout, with a disclosed facilitation fee at payment and $0/mo plus pass-through pricing and 9% facilitation. COGS is readable before you commit, so you can set patient pricing and project gross margin from day one.

Batching the whole refill day in one cart reinforces the model: each line shows its drug cost, so you see total COGS for the session and the margin it implies before you pay. Clinic owners managing to a target gross margin on GLP-1 programs get a faster loop — see cost, set price, confirm spread — without waiting for tier onboarding to reveal the most important P&L line.

Budget platform tiers first — or model drug COGS before you commit?

RxFul fits if

RxFul

You are launching a patient-facing brand and can finalize drug COGS during onboarding.

  • Your P&L already separates white-label platform spend from medication COGS and you budget SaaS monthly.
  • You need clinic-branded patient checkout more than prescriber-side batch cart economics today.
  • You can confirm per-vial fulfillment and drug rates in writing before you lock patient program pricing.
Consider Fizy Health if

Fizy Health

You want drug COGS visible before you build patient pricing.

  • You manage to a target gross margin and need per-vial 503A cost on screen before checkout.
  • Your prescribers batch refills and want total session COGS visible before one payment.
  • You want to compare landed cost across 503A partners without paying $997/mo to unlock the catalog first.
FAQ

Clinic P&L questions about RxFul pricing.

  • Fixed cost

    What is the minimum RxFul platform cost for a full formulary?

    Rx-Bronze at $997/mo is the published entry point for full SKU catalog, peptides, and cold-chain access. That is fixed SaaS cost regardless of order volume until you upgrade.

  • Variable cost

    What variable costs sit on top of the monthly tier?

    Compounded medication cost and 3PL fulfillment fees are variable. Silver and Gold add volume-based fulfillment pricing — confirm per-order rates at your expected volume in writing.

  • GLP-1

    Can a GLP-only clinic avoid the $997/mo Bronze tier?

    Yes. Rx-GLP at $0/mo includes GLP product access only. If you add peptides, hormones, or SKUs outside GLP, you need Bronze or above.

  • Margin

    When can I confirm gross margin on my patient programs?

    You can budget platform cost from published tiers immediately. Drug COGS requires onboarding quotes — ask for per-vial rates on your top SKUs before you lock patient pricing.

  • Comparison

    How does Fizy Health affect clinic P&L planning?

    Fizy Health shows per-vial 503A cost before checkout with $0/mo plus pass-through pricing and 9% facilitation. Drug COGS is visible the same day you sign up, which speeds margin modeling for cash-pay programs.

  • Volume

    Does higher RxFul tier always mean lower landed cost?

    Not automatically. Gold adds features and priority allocation, and Silver/Gold include volume-based fulfillment pricing that may improve logistics cost at scale. Model total landed cost — SaaS plus drug plus fulfillment — at your actual order count.

Sources reviewed June 2026

  • RxFul public website and pricing page (rxful.com/pricing), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Model drug COGS before you pick a platform tier.

Compare pass-through per-vial cost on your top SKUs, build one batch cart, and read margin before you commit. Free to start.